Two cases of hemolytic uremic syndrome caused by Streptococcus pneumoniae serotype 3, one being a vaccine failure

References

• Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R. [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia]. Schweiz Med Wochenschr 1955;85:905–9.
   PubMedGoogle Scholar
• Copelovitch L, Kaplan BS. Streptococcus pneumoniae—associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics 2010;125:e174–82.
   PubMed Web of Science ®Google Scholar
• Fischer K, Poschmann A, Oster H.[Severe pneumonia with hemolysis caused by neuraminidase. Detection of cryptantigens by indirect immunofluorescent technic]. Monatsschr Kinderheilkd 1971;119:2–8.
   PubMedGoogle Scholar
• Kaplan SL, Mason EO Jr, Barson WJ, Wald ER, Arditi M, Tan TQ, et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 1998;102:538–45.
   PubMed Web of Science ®Google Scholar
• Waters AM, Kerecuk L, Luk D, Haq MR, Fitzpatrick MM, Gilbert RD, et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr 2007;151:140–4.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction—eight states, 1998–2005. MMWR Morb Mortal Wkly Rep 2008;57:144–8.
   PubMedGoogle Scholar
• Bender JM, Ampofo K, Byington CL, Grinsell M, Korgenski K, Daly JA, et al. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J 2010;29:712–6.
   PubMedGoogle Scholar
• Liu QP, Sulzenbacher G, Yuan H, Bennett EP, Pietz G, Saunders K, et al. Bacterial glycosidases for the production of universal red blood cells. Nat Biotechnol 2007;25: 454–64.
   PubMed Web of Science ®Google Scholar
• Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006;25:250–4.
   PubMed Web of Science ®Google Scholar
• Darenberg J, Henriques Normark B. The epidemiology of pneumococcal infections—the Swedish experience. Vaccine 2009;27(Suppl 6):G27–32.
   Google Scholar
• Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter?Clin Infect Dis 2008;46: 1346–52.
   PubMed Web of Science ®Google Scholar
• Hsieh YC, Hsiao CH, Tsao PN, Wang JY, Hsueh PR, Chiang BL, et al. Necrotizing pneumococcal pneumonia in children: the role of pulmonary gangrene. Pediatr Pulmonol 2006;41:623–9.
   PubMedGoogle Scholar
• Vanderkooi OG, Kellner JD, Wade AW, Jadavji T, Midgley JP, Louie T, et al. Invasive Streptococcus pneumoniae infection causing hemolytic uremic syndrome in children: two recent cases. Can J Infect Dis 2003;14:339–43.
   PubMedGoogle Scholar
• Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, Ruckinger S, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010;51:692–9.
   PubMed Web of Science ®Google Scholar
• Poolman J, Kriz P, Feron C, Di-Paolo E, Henckaerts I, Miseur A, et al. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics. Vaccine 2009;27:3213–22.
   PubMed Web of Science ®Google Scholar
• Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006;367:740–8.
   PubMed Web of Science ®Google Scholar
• Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines 2011;10: 307–22.
   PubMed Web of Science ®Google Scholar
• Vanderkooi OG, Scheifele DW, Girgenti D, Halperin SA, Patterson SD, Gruber WC, et al. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada. Pediatr Infect Dis J 2012;31:72–7.
   PubMed Web of Science ®Google Scholar
• Frenck R Jr, Thompson A, Yeh SH, London A, Sidhu MS, Patterson S, et al. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2011;30:1086–91.
   PubMed Web of Science ®Google Scholar
• . Personal communicationAttelind S. Uppsala: Swedish Medical Agency; 2012.
   Google Scholar